A randomized trial of EPOCH-based chemotherapy with vorinostat for highly aggressive HIV-associated lymphomas: Updated results evaluating impact of diagnosis-to-treatment interval (DTI) and pre-protocol systemic therapy on outcomes Meeting Abstract
| Authors: | Ramos, J. C.; Sparano, J.; Moore, P. C.; Siegel, E.; Lee, J. Y.; Reid, E. G.; Ambinder, R. F.; Chadburn, A.; Rubinstein, P. G.; Durand, C.; Cesarman, E.; Ratner, L.; Baiocchi, R. A.; Aboulafia, D. M.; Kaplan, L. D.; Capoferri, A.; Mitsuyasu, R. T.; Noy, A. |
| Abstract Title: | A randomized trial of EPOCH-based chemotherapy with vorinostat for highly aggressive HIV-associated lymphomas: Updated results evaluating impact of diagnosis-to-treatment interval (DTI) and pre-protocol systemic therapy on outcomes |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160402140 |
| DOI: | 10.1182/blood-2019-129687 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1588 -- Source: Wos |
